CAS#:80714-61-0
Semax
Size
Research Profile
Semax
Literature-based research context for laboratory reference only.
Semax is a synthetic heptapeptide derived from the N-terminal fragment of ACTH (4–10). Developed at the Institute of Molecular Genetics in Russia, it has been studied for nootropic, neuroprotective, and BDNF-upregulating properties in ischemia and cognitive function research.
Selected literature
- Gusev et al., 1997, Neuroscience and Behavioral Physiology.
This page is provided for laboratory reference and literature review only. The material is not presented as a consumer product, medical treatment, diagnostic tool, or recommendation for human or animal use.
Overview
Semax is presented here as a laboratory reference entry. The Research Profile summarizes literature-based biological context, while this Overview documents the identity record, specification set, preparation format, and quality-reference information available on the page.
The identity block lists CAS number 80714-61-0, molecular formula C₃₇H₅₁N₉O₈, and molecular weight 751.9 Da. The material record is paired with ≥99% purity information and a lyophilized presentation for reference review.
Available specification labels include 5mg, 10mg, and 30mg. The active selection is 5mg; changing the selector updates the visible specification label and COA lot references while preserving the same research-reference context.
For the active selection, the page currently shows 1 active COA lot reference. COA links, when present, are retained for batch-level purity, identity, and quantity review, while packaging and storage details remain separated in Structure & Identity.